AlphaYou
Overview
No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.
Key stats
Aug 20- 52-wk high
- $31.77
- 52-wk low
- $15.10
- Prev close
- $20.69
- Mkt cap
- $3.33B
- P/E
- 120.3x
- Fwd P/E
- 60.2x
Smart money
Earnings
Earnings came in $0.02 a share above what analysts expected.
Financials
What it sold, what it cost, what was left.
Sep 2025Dec 2025Mar 2026Jun 2026
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $99.2M | $129.5M | $105.4M | $129.9M |
| Cost of what it sold | $8.7M | $11.7M | $9.8M | $10.9M |
| Gross profit | $90.5M | $117.8M | $95.6M | $118.9M |
| What it spent | ||||
| Research and development | $19.6M | $20.5M | $30.6M | $20.4M |
| Sales and admin | $62.4M | $79.0M | $74.1M | $82.1M |
| Total operating expenses | $82.0M | $99.4M | $104.7M | $102.5M |
| What was left | ||||
| Operating profit | $8.5M | $18.4M | -$9.1M | $16.4M |
| Interest on debt | $3.1M | $3.0M | $4.4M | $3.4M |
| Profit before tax | $7.5M | $17.9M | -$11.2M | $15.1M |
| Tax | $80.0K | $470.0K | $93.0K | $136.0K |
| Net profit | $7.4M | $17.4M | -$11.3M | $15.0M |
| EBITDA | $11.1M | $22.1M | -$6.3M | $17.1M |
Technicals
Price structure
No data yet
Technicals sync when verified market data is available. No sample data is shown.
News
What the news says
23 articles · 7 days
Coverage is bullish
Tone of tracked coverage
Arcutis (NASDAQ: ARQT) holder plans $123,834 August sale
NeutralAug 17Should Arcutis Biotherapeutics’ (ARQT) Strong Q2 and Higher 2026 Sales Outlook Prompt Investor Action?
BullishAug 17Polar Capital discloses 5.28% Arcutis Biotherapeutics (ARQT) ownership in Schedule 13G
NeutralAug 14
